Senior insider sale
KALVISTA PHARMACEUTICALS, INC. — senior position signals high conviction
$180.0K
18K shares
What this filing means
CHA ALBERT plans to sell 18K shares of KALVISTA PHARMACEUTICALS, INC. valued at approximately $180.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/11/2023ACC: 0001972362-23-000794
18K
Shares to sell
$180.0K
Approx. market value
18K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
STOCK OPTION EXERCISE
COMPENSATION
9/11/2023
18KTotal acquired18K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/11/2023 | STOCK OPTION EXERCISE COMPENSATION | 18K | — |
| Total | 18K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
18K
Market value
$180.0K
9/11/2023
Total
Units
18K
Value
$180.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/11/2023 | 18K | $180.0K | NASDAQ | Planned |
| Total | 18K | $180.0K | ||